Symbols

ANTX

AN2 Therapeutics·NASDAQ

--(--)

ANTX Profile

An2 Therapeutics, Inc.

A biopharmaceutical company focused on developing treatments for infectious diseases and cancer

Industry

Pharmaceutical

Established Date

02/24/2017

Listing Date

03/25/2022

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.an2therapeutics.com

Security Type

Common stock

Office address

1300 El Camino Real, Suite 100, Menlo Park, California 94025

Business

Introduction

AN2 Therapeutics, Inc., was incorporated in Delaware on February 24, 2017 and commenced operations in November 2019. The Company is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapies using its boron chemistry platform. Its R&D pipeline targets the fields of blood diseases, infectious diseases and oncology.